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Abstract
Background: Autism is a highly varied and heritable neurodevelopmental condition, and common variants explain
approximately 50% of the genetic variance of autism. One of the genes implicated in autism is the oxytocin
receptor (OXTR). The current study combined genetic and brain imaging (fMRI) data to examine the moderating
effect of genotype on the association between diagnosis and brain activity in response to a test of cognitive
empathy.
Methods: Participants were adolescents (mean age = 14.7 ± 1.7) who were genotyped for single nucleotide
polymorphisms (SNPs) within the OXTR and underwent functional brain imaging while completing the adolescent
version of the ‘Reading the Mind in the Eyes’ Test (Eyes Test).
Results: Two (rs2254298, rs53576) of the five OXTR SNPs examined were significantly associated with brain activity
during the Eyes Test, and three of the SNPs (rs2254298, rs53576, rs2268491) interacted with diagnostic status to
predict brain activity. All of the effects localized to the right supramarginal gyrus (rSMG) and an overlap analysis
revealed a large overlap of the effects. An exploratory analysis showed that activity within an anatomically defined
rSMG and genotype can predict diagnostic status with reasonable accuracy.
Conclusions: This is one of the first studies to investigate OXTR and brain function in autism. The findings suggest
a neurogenetic mechanism by which OXTR-dependent activity within the rSMG is related to the aetiology of
autism.
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Background
Autism is a highly varied neurodevelopmental condition
characterised by deficits in social interaction and com-
munication, alongside unusually repetitive behaviour
and extremely narrow interests. Other characteristics of
autism include a resistance to unexpected change and
atypical sensory sensitivity (DSM-5, 2013).
One of the main characteristics of autism is difficulties
in social cognition, and in particular cognitive empathy
[1]. Cognitive empathy is defined as the ability to iden-
tify the mental state of the other [2]. One of the most
well-validated and widely used measures of cognitive
empathy is the ‘Reading the Mind in the Eyes’ Test (Eyes
Test) [3]. Individuals diagnosed with autism tend to
score lower on this measure than controls [3, 4], and
other measures of social cognition show the same pat-
tern [1, 3, 5]. A recent study found that certain sub-
groups within autism score lower than others [6] and a
whole genome association study of performance on the
Eyes Test suggests modest but significant heritability [7].
Autism manifests considerable heterogeneity, varying
in clinical presentation across a spectrum of behaviours,
as well as in levels of intellectual impairment and degree
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of delay in language development [6, 8]. In line with this,
the genetic aetiology of autism is heterogeneous and
hundreds of genes are hypothesised to be implicated [9],
with about 50% of the genetic effect attributed to com-
mon genetic variations [10]. This phenotypic and genetic
heterogeneity is also evident in studies of the brain [11].
Studies of the anatomical and functional brain differ-
ences in autism versus typically developing individuals
yield mixed results [12, 13]. One way of gaining add-
itional insight into the biological basis of autism is by
combining data regarding genetic variation and brain
imaging in a single analysis [14, 15]. This is the aim of
the current investigation.
Oxytocin
Here, we focused specifically on the oxytocin receptor
(OXTR) gene, as it has been previously linked with social
cognition and behaviour in the typical population, as
well as with autism [16]. Oxytocin (OXT) is a nonapep-
tide with a long evolutionary history and a
well-established role in animal and human social behav-
iour and cognition [17]. OXT has a major role in the ‘so-
cial brain’, i.e. in brain regions that have been clearly
associated with social cognition [18, 19]. The ‘social
brain’ includes areas such as the amygdala, insula, med-
ial prefrontal cortex, superior temporal sulcus, anterior
cingulate cortex, temporoparietal junction, and inferior
parietal lobule [20, 21]. The effects of OXT on the social
brain are likely mediated by its receptor—the OXTR. In-
deed, a recent study using in vivo arterial spin labelling
to identify changes in cerebral blood flow following in-
tranasal administration of OXT implicated many areas
within the social brain [22], suggesting a broad expres-
sion pattern of the OXTR. An analysis of OXTR expres-
sion patterns using RNAseq revealed that it is broadly
expressed in subcortical and cortical regions [23].
Association of OXTR with both social cognition and autism
Single nucleotide polymorphisms (SNPs) in the OXTR
have been associated with autism in different popula-
tions [24–30], especially related to the social domain in
autism [31, 32], although null-findings are also reported
[33–35]. Epigenetic markers on the OXTR have also
been associated with autism [36, 37], and oxytocin
(OXT) administration has been shown to improve social
symptoms in autism [38–45] (but see also [46]). Similar
findings of association between OXTR and social cogni-
tion have been reported for typical populations, includ-
ing an association with performance on the Eyes Test
[47, 48] and empathy [49, 50], as well as with prosocial
behaviour [51, 52], partner bonding [53], parent-child re-
lationship [54], and others.
The involvement of the OXT system in social cogni-
tion is further supported by studies in which participants
are given intranasal doses of OXT. In these studies,
OXT administration is shown to increase cognitive em-
pathy, including as measured by the Eyes Test [43, 55,
56]. Taken together, these findings suggest two conclu-
sions. First, OXT is associated with social cognition and
social behaviour across the entire spectrum of social
ability—both in typical population and in autism. Sec-
ond, OXT and OXTR are also associated with individual
differences in social cognition and behaviour [57]. For
example, OXT administration had a stronger effect in
improving empathic accuracy for those scoring higher
on the autism spectrum quotient (AQ; [58]), i.e. typical
males with higher levels of autistic traits [59]. Similarly,
those who had the most impaired eye-contact also im-
proved the most after receiving a dose of OXT [44].
Oxytocin in the brain
Most studies of the role of OXT in the brain are con-
ducted in typical populations and utilise intranasal ad-
ministration of OXT. These studies typically find that
OXT induces decreased activation in the amygdala dur-
ing emotion processing, although this effect may differ
in men and women [18, 60, 61]. Few studies have exam-
ined the effects of OXT in autism, and these usually
show that OXT administration is associated with the re-
covery of a typical pattern of activation in certain brain
areas [40, 62]. Moreover, a recent study extended these
findings by showing that the effect of OXT administra-
tion on brain function (increased activity and connectiv-
ity between dorsal anterior cingulate cortex (ACC) and
dorsomedial prefrontal cortex (dmPFC)) is dependent
on OXTR genotype [63].
One other previous study combined imaging and gen-
etics to study OXTR in autism, and that study focused
on the reward circuitry and especially the nucleus ac-
cumbens (NAcc) [64]. Their findings show an OXTR-de-
pendent change in the connectivity of the reward
circuitry in children with autism during resting state.
Apart from this study, all other imaging genetics studies
of OXTR conducted in typical Caucasian or
non-Caucasian populations [50, 65–73] implicate the
structure and function of the amygdala and the hypo-
thalamus as most associated with OXTR genotype, but
also find associations with other parts of the social brain,
such as the striatum and dmPFC. Moreover, a recent
study reported a sex-specific association between the
OXTR SNP rs2254298 and connectivity in the default
mode network (DMN) [72]. Due to the broad distribu-
tion of the OXTR and evidence for its potential to affect
many brain areas [22, 23, 60, 72], we chose an uncon-
strained whole-brain analysis approach. The aim of the
current study was to better understand the complex
interaction between oxytocin genotype, brain function,
and autism, by integrating OXTR genotype and brain
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imaging data in a sample of adolescents (aged 12.01–
18.53 years) with and without an autism diagnosis. Here,
we focused on social cognition, and specifically the abil-
ity to recognise emotions, which is a hallmark difficulty
in autism [3]. This is one of the first studies, to our
knowledge, to take an imaging genetics approach to bet-
ter understand the oxytocin-related aetiology of social
cognition deficits in autism.
Methods
Participants
The participants of the current study are a subsample of
those that participated in a previous study [74] who had
provided DNA samples and had valid genotyping results.
These were 38 adolescents aged 12–18 years (mean age
14.38 ± 1.69, 10 females) who were diagnosed with
high-functioning autism or Asperger syndrome (hence-
forth, the autism group) and 33 (mean age 15.01 ± 1.69,
17 females) were neurotypically developing (henceforth,
controls). Participants in the autism group had no other
comorbidities, and diagnosis was confirmed using the
Autism Diagnostic Observational Schedule—Generic
(ADOS-G; [75]) and the Autism Diagnostic Interview—
Revised (ADI-R; [76]). Participants with current or past
medication use were not included in the current study.
Details of the participants used in the current study ap-
pear in Table 1.
Behavioral measures
Participants’ intelligence quotient (IQ) was assessed
using the Wechsler Abbreviated Scale of Intelligence
(WASI; [77]). In addition, parents reported on their
child’s autistic traits, using the adolescent version of the
autism spectrum quotient (AQ; [78]). See details in
Table 1.
DNA extraction and genotyping
Samples were collected using buccal swabs. DNA was
extracted using the protocol described previously [79], at
the Institute of Psychiatry, SGDP research centre, UK.
Samples were genotyped by LGC Genomics Ltd. at Hod-
desdon, UK, using PCR-based KASP technology.
Genotyping was conducted for seven oxytocin receptor
(OXTR) single nucleotide olymorphisms (SNPs)—
rs7632287, rs2268491, rs237887, rs2254298, rs53576,
rs2268493, and rs2228485. These SNPs were selected
based on previous studies of associations with autism
risk or individual variability in empathy and emotion
recognition (see Table 2). Two of the SNPs had ex-
tremely low variability in the current sample
(rs237887—only two no-risk carriers in the control
group, and rs2268493—only two no-risk carriers in con-
trol and autism groups each). These SNPs were not ana-
lysed further. Analysis of linkage disequilibrium was
conducted using LDlink [80] and the 1000 Genomes
project database of European samples (see Fig. 1). Some
of the SNP pairs had high D’ values but low R2 values,
and therefore were still analysed separately. The pair
rs2268491-rs2254298 was in high LD on both measures,
and we refer to this in the “Discussion” section. For all
SNPs, the high-risk allele carriers were compared to
those homozygous for the low-risk allele. The distribu-
tion of genotype did not differ significantly between the
diagnostic groups (χ2 > .056 for all SNP × group
analyses).
fMRI task
Participants completed the adolescent version of the
‘Reading the Mind in the Eyes’ test (Eyes Test) as previ-
ously described [74]. The adolescent version of the Eyes
Test is a simplified and fMRI suitable version of the
adult test [3]. In this test, participants are presented with
32 pictures of the eye area and are asked to choose one
of two words that best describes the mental state of the
person depicted in each picture. A sex-judgment task
using the same 32 pictures as stimuli was used as a con-
trol condition. The resulting contrast essentially allows
to compare the difference between automatic processes
of emotion recognition and explicit processing of emo-
tional cues. In both cases, choice was indicted by press-
ing one of the two buttons on a button box held in their
right hand. The tasks were organised in blocks of 23 s
that included the presentation of four pictures for 5 s
each, an inter-stimulus interval of 0.75 s, and an
Table 1 Sample demographics
Autism group Control group Significance testing
Mean (± SD) Range Mean (± SD) Range
Age 14.38 (1.69) 12.01–18.53 15.01 (1.69) 12.08–17.62 t (69)= − 1.57, p = .121
Full-scale IQ 106.11 (16.73) 76–146 112.18 (11.62) 83–136 t (69)= − 1.75, p = .084
Verbal IQ 106.16 (19.48) 70–150 111.27 (12.22) 87–142 t (69)= − 1.30, p = .197
Performance IQ 104.92 (15.95) 70–141 110.58 (10.94) 83–132 t (69)= − 1.72, p = .091
AQ 39 (6.47) 19–49 9.58 (5.99) 1–24 t (69) = 19.78, p < .001
ADOS total 11.50 (4.18) 7–26
IQ intelligence quotient, AQ autism spectrum quotient, SRS Social Responsiveness Scale
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interblock interval of 2 s. A total of 16 blocks were pre-
sented (8 mental state and 8 sex judgment), resulting in
an overall presentation time of 7 min. The order of the
blocks was counterbalanced across participants in each
group. The stimuli were presented using e-Prime version
2.0 professional (Psychological Software Tools, USA).
fMRI collection and preprocessing
Participants were scanned using a Siemens 3-T Tim Trio
scanner (Siemens Healthcare, Germany) at the Medical
Research Council Cognition and Brain Sciences Unit
(MRC CBU) in Cambridge, UK. Echoplanar imaging
(EPI) was collected with the following parameters: repe-
tition time (TR) = 2000 ms, echo time (TE) = 30ms,
voxel size 3 × 3 × 3mm, 32 slices acquired sequentially
descending in the transverse plane with a slice thickness
of 3 mm and an interslice gap of 0.75 mm, and flip angle
= 60°. A structural image (magnetization prepared rapid
gradient echo: MPRAGE) was also acquired for
co-registration and normalisation purposes, with the
Table 2 Studies that implicate OXTR SNPs in autism and social cognition
SNP Major/minor frequency allele Associated with References
rs2254298 G/A Autism and autistic traits [28–30, 32, 87, 88]
Social cognition [35, 89–93]
rs53576 G/A Autism [29, 31, 88, 94, 95]
Social cognition [35, 50, 52, 55, 75, 92, 96] [101]
rs2268491 C/T Autism [28]
Social cognition [89], [102]
rs7632287 G/A Autism [28, 34]
Social traits in autism [103]
Social cognition [89]
rs237887 A/G Autism [28]
Social cognition [89], [102]
rs2268493 T/C Autism [27]
rs2228485 T/C Social cognition [104]
Fig. 1 Linkage disequilibrium analysis. The SNP which were included in the analyses were examined for linkage disequilibrium (LD). The figure
containing SNP’s locations was automatically created by LDlink [80]
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following parameters: voxel size 1 × 1 × 1mm, TR =
2250 ms, TE = 2.98 ms, inversion time (TI) = 900 ms, flip
angle = 9°, and total scan time 4min 32 s.
Preprocessing was done using the SPM12 package
(Wellcome Trust Centre for Neuroimaging, UK, http://
www.fil.ion.ucl.ac.uk/spm). Each volume was first
slice-time corrected using the middle slice as a refer-
ence. Slice-time corrected volumes were spatially aligned
to the first volume. In order to maximise the best pos-
sible individual normalisation, we chose a unified seg-
mentation approach [81] to indirectly normalise images
to MNI space. Individual T1-weighted images were first
co-registered to the realigned fMRI volumes. Segmenta-
tion was done based on a template created using the
Template-O-Matic toolbox [82] in SPM8. This toolbox
generates tissue maps that are based on a healthy
pediatric sample and are made study-specific based on
the age and sex composition of the sample used. Param-
eters from the T1 normalisation were then applied to
the functional volumes, and these were subsequently
resliced to 2-mm isotropic voxels. We chose this reso-
lution in order to maintain compatibility with a previous
publication which used a bigger version of the same
dataset [74]. However, we have used a relatively stringent
criterion for significance testing, with all family-wise
error (FWE) at p < .001. Finally, an 8-mm
full-width-half-maximum (FWHM) smoothing kernel
was applied. An analysis of residual head motion during
scanning using DVARS (i.e., the spatial root mean square
of the data after temporal differencing) revealed no
group differences (Additional file 1: Figure S1).
Imaging analysis
For each participant, a first-level analysis was preformed
comparing hemodynamic response during mental state
vs. sex judgment (F-contrast), thus controlling for other
aspects of the task. Next, a second-level, full-factorial
analysis using a whole-brain approach was conducted
with diagnosis and genotype (2 × 2) as fixed factors and
sex and age as nuisance covariates. The analysis was
conducted for each SNP separately. Statistical outcomes
were corrected for multiple comparisons using a
family-wise error (FWE) correction based on the cluster
size. We also report the identified cluster size for each
analysis. The SPM Anatomy toolbox was used to identify
the significant clusters [83]. The MarsBaR toolbox [84]
was used to extract the coefficients for each participant
at each of the clusters identified in the previous analyses
(clusters defined by main and interaction effects for
rs2254298 and rs53576 and a cluster defined by an inter-
action effect for rs2268491). We then examined the cor-
relation between the average activation levels and AQ
scores within the autism and control groups separately.
Overlap analysis was conducted using the fslmaths
function in FSL [85]. Visualisation and labelling were
done using MRIcron [86] and the Automated Anatom-
ical Labelling Atlas [87].
Exploratory analysis of anatomical region of interest
Based on the findings described below, an exploratory of
the activation within an anatomically defined rSMG was
conducted. An anatomical mask was created using the
Anatomy toolbox [83] in SPM12 (Wellcome Trust
Centre for Neuroimaging, UK, http://www.fil.ion.ucl.a-
c.uk/spm, based on the following cytoarchitectonic areas
PF, PFcm, PFm, PFop, and PFt). For each participant, a
first-level analysis was preformed comparing
hemodynamic response during mental state vs. sex judg-
ment (t-contrast), and a second-level analysis with solely
sex and age as nuisance covariates, thus creating a map
of activation with no factorial constraints. Afterwards,
MarsBaR [84] was used to extract the mean activation
level for each participant within the anatomically defined
rSMG. These values were used within a logistic regres-
sion along with genotype and the interaction between
them to predict diagnostic status (autism/control). The
analysis was conducted in SPSS v22, IBM, Inc.
Results
Participants in the autism group were significantly less
accurate in their mental state judgements on the Eyes
Test than the control group (M = 24.03, SD = 6.99 and
M = 27.76, SD = 2.29 respectively, t (61)= − 2.90, Cohen’s
d = 0.72, p = .005). However, once genotype was consid-
ered as well (and sex and age were controlled for, as in
the imaging analyses below), this effect disappeared (all
p values > .083).
Genotype distributions
Autism and control groups did not differ on genotype
distribution for any of the examined SNPs, AQ ratings,
or RMET scores. The exception was for rs7632287, for
which the major frequency (low risk) genotype appeared
more frequently than expected in the autism group, and
scored higher on the AQ, as compared to the
low-frequency (high risk) genotype (see Table 3).
Imaging genetic analysis
For each of the five SNPs that were analysed, a main ef-
fect of diagnosis, genotype, and the interaction between
the two factors was examined (2 × 2). In none of the
analyses was diagnosis a significant predictor of activa-
tion. We report the nominal p value for these analyses
and interpret the results based on a more stringent
Bonferroni-corrected significance criterion of p = .01, in
order to control for the testing of the five SNPs.
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rs2254298 Genotype of rs2254298 was associated with
significant hyperactivation in an area corresponding to
the right supramarginal gyrus (rSMG) and the right in-
ferior parietal lobule (rIPL) (F (1, 60) = 11.97, nominal p
value (FWE-corr) = 0.010, cluster size = 163), as was the
interaction between genotype and diagnosis (nominal p
value (FWE-corr) = 0.009, cluster size = 164). Figure 2 pre-
sents the beta values extracted from the active cluster
stratified by group and genotype. The effect is driven by
hyperactivation in A-carriers in the control group.
rs53576 Genotype of rs53576 was also associated with
significant hyperactivation in an area corresponding to
the rSMG and rIPL (F (1, 60) = 11.97, nominal p value
(FWE-corr) = 0.006, cluster size = 157). The interaction be-
tween genotype and diagnosis was only nominally sig-
nificant (nominal p value (FWE-corr) = 0.034, cluster size =
114). Figure 3 presents the beta values extracted from
the active cluster stratified by group and genotype. The
effect is driven by hyperactivation in GG-carriers in the
control group.
rs2268491 For this SNP, only the interaction between
genotype and diagnosis, but not the genotype, was asso-
ciated with a differential activation in an area corre-
sponding to the rSMG and rIPL (F (1, 60) = 11.93,
nominal p value (FWE-corr) = 0.009, cluster size = 160).
The effect was driven by hyperactivation in the control
T-carriers. See Fig. 4.
The SNPs rs2228485 and rs7632287 or their interac-
tions with diagnosis did not yield any cluster that sur-
vived the family-wise error correction.
Overlap analysis As all the effects localised to the
rSMG and rIPL, we turned to investigate the degree of
overlap between these effects. We included all nominally
significant effects in the following analyses: (1) overlap
of genotype and interaction effect for each SNP, (2) over-
lap of main effects across SNPs, and (3) overlap of the
genotype by diagnosis effects across SNPs.
Table 3 Distributions by genotype
Genotype Autism Control AQ RMET
rs53576 GG 15 6 31 80.76
A 23 26 23.67 81.1
Χ2 = 0.059 F = 3.11 F = .005
rs2268491 CC 27 28 23.84 80.72
T 12 5 31.12 82.62
Χ2 = 0.12 F = 2.73 F = .15
rs2254298 GG 27 27 24.09 80.43
A 11 5 31.13 85.42
Χ2 = 0.186 F = 2.38 F = 1.07
rs7632287 GG 28 15 29.72 82.86
A 11 18 19.38 79.13
Χ2 = 5.156* F = 7.89* F = .758
rs2228485 TT 22 16 27.08 81.74
C 17 16 24.27 80.21
Χ2 = 0.290 F = .535 F = .725
AQ autism spectrum quotient (adolescent version) [81]
*p < .05
Fig. 2 Whole brain analysis of activity in response to a social decision task, depending on OXTR rs2254298 genotype and diagnostic status. Note:
a Mean activation within the significant cluster stratified by OXTR rs2254298 genotype and diagnostic group. The mean values are based on the
interaction analysis. Genotype was grouped based on the A-allele (GG vs GA and AA). The main effect of genotype and the interaction between
genotype and diagnostic group were significant at corrected p < .01. b The corresponding activation map for the main effect of rs2254298
genotype. c The corresponding activation map for the interaction effect between rs2254298 genotype and diagnostic status
Uzefovsky et al. Molecular Autism           (2019) 10:12 Page 6 of 13
(1) For rs2254298, the area activated depending on the
genotype and the area activated depending on the
interaction between genotype and diagnosis
overlapped by 89 voxels or 54.60% (size of main
effect served as the basis), within the rSMG
(Fig. 5a). The same overlap for rs53576 was of
31.21% or 40 voxels within the rSMG and rIPL
(Fig. 5b). For rs2268491, only an interaction effect
was significant; therefore, no overlap effect was
calculated.
(2) The overlap between the main effects of rs2254298
and rs53576 was calculated as 51 voxels or 31.29%
Fig. 3 Whole brain analysis of activity in response to a social decision task, depending on OXTR rs53576 genotype and diagnostic status. Note: a
Mean activation within the significant cluster stratified by OXTR rs53576 genotype and diagnostic group. The mean values are based on the
interaction analysis. Genotype was grouped based on the A-allele (GG vs GA and AA). The main effect of genotype and the interaction between
genotype and diagnostic group were significant at corrected p < .05. b The corresponding activation map for the main effect of rs53576
genotype. c The corresponding activation map for the interaction effect between rs53576 genotype and diagnostic status
Fig. 4 Whole brain analysis of activity in response to a social decision task, depending on OXTR rs2268491 genotype and diagnostic status. Note:
a Mean activation within the significant cluster stratified by OXTR rs2268491 genotype and diagnostic group. The mean values are based on the
interaction analysis. Genotype was grouped based on the T-allele (CC vs CT and TT). The interaction between genotype and diagnostic group
was significant at corrected p < .01. b The corresponding activation map for the interaction effect of rs2268491 genotype and diagnostic status
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(size of the effect for rs2254298 served as the basis)
within the rSMG (Fig. 6, top panel).
(3) The overlap between the interaction effects of
rs2254298 and rs2268491 was 156 voxels or 95.12%
(size of the effect for rs2254298 served as basis)
within the rSMG. The overlap between this and the
interaction effect of rs53576 was 26 voxels or
15.85% (again, size of the effect for rs2254298
served as basis) within the rSMG. That is, two of
the interaction effects (rs2254298 and rs2268491)
localised to largely the same area, whereas the
interaction effect of rs53576 localized to a slightly
different region of the rSMG (Fig. 6, bottom panel).
Association with autistic traits For each of the signifi-
cant findings, MarsBaR [84] was used to extract mean
activation values for each participant. The correlation
between activation and the adolescent version of the aut-
ism spectrum quotient (AQ; [78] was examined. As can
be seen in Table 4, hyperactivation associated with the
interaction between rs53576 genotype and diagnosis was
nominally associated with the AQ score in the autism
group. However, this association was not significant
based on the Bonferroni-corrected p value of p = .01.
Predicting diagnosis Based on these findings, we
undertook an exploratory analysis, to check whether
genotype and activation within an anatomically defined
rSMG can predict diagnostic status. We conducted a lo-
gistic regression for each SNP with diagnostic status
(autism/control) as the dependent variable. For all three
SNP’s, the models achieved good accuracy in the correct
classification of individual participants to diagnostic
groups. With the major caveat that this is an exploratory
analysis, this suggests that activation in the rSMG in re-
sponse to mental state judgments and the interaction be-
tween activation and OXTR SNP’s can predict diagnostic
status. See Table 5 for details.
Discussion
The current investigation aimed to understand the links
between oxytocin receptor genotype, brain activity in re-
sponse to an explicit cognitive empathy task, and autism.
As autism encompasses a spectrum of manifestations,
we expected to find subgrouping within those diagnosed
with autism. We found that diagnostic status interacts
with OXTR genotype to predict activation within the
right supramarginal gyrus and the right inferior parietal
lobule during a mental state judgment task. Two
(rs2268491 and rs2254298, with rs53576 showing the
Fig. 5 Overlap of activated clusters for the rs2254298 and rs53576 main and interaction effects. Note: a Overlap between the area associated with
the effect of rs2254298 genotype (in green) and the effect of the interaction between rs2254298 genotype and diagnostic status (in red). b
Overlap between the area associated with the effect of rs53576 genotype (in green) and the effect of the interaction between rs53576 genotype
and diagnostic status (in red)
Uzefovsky et al. Molecular Autism           (2019) 10:12 Page 8 of 13
same effect nominally) out of the five SNPs examined
showed a similar effect of differential activation based
on diagnostic status, and two of the SNPs (rs2254298
and rs53576) were associated with activation, all within
the rSMG and rIPL. Interestingly, the interaction
showed a crossover effect, whereby an allele showing
overactivation in the control group shows underactiva-
tion in the autism group and vice versa. The effects not
only localised to the rSMG, but largely to the same clus-
ter within the rSMG (with some distinct effect for the
interaction between rs53576 and diagnosis, which was
only nominally significant). The degree of the overlap in
effect between rs2254298 and rs2268491 is expected as
these two SNPs are in high LD (R2 = .98, D’ = 1). Other
SNP pairs show moderate LD (rs53576 with rs2268491;
R2 = .021, D’ = .56 and with rs2254298; R2 = .019, D’
= .54). As such, these consistent findings suggest an
overall effect for the OXTR gene within this possibly
functional locus, and in particular implicate the rSMG.
Moreover, activation within an anatomically defined
rSMG predicted diagnostic status in analysis of two of
the three analysed OXTR SNPs (rs2254298, rs2268491),
and the interaction between activation and genotype was
significant for all three SNPs.
The effects of OXTR genotype localise to the rSMG,
and this is in line with a study showing that OXTR
methylation is associated with activity in the supramargi-
nal gyrus and the dorsal anterior cingulate cortex (ACC)
[37]. Interestingly, an fMRI study that investigated emo-
tional egocentricity bias (EEB) found that overcoming
such bias, i.e. being able to empathise with another even
when the other’s feelings differ from your own, is related
to hyperactivity of the rSMG. Moreover, disrupting the
activity of the rSMG using transcranial magnetic stimu-
lation (TMS) resulted in increased bias [88]. In the
above-mentioned study, EEB was manipulated using a
touch paradigm in which participants rated the pleasant-
ness of tactile stimulation for themselves and another
participant while experiencing either congruent or in-
congruent stimulation. The difference between
Fig. 6 Overlap of activated clusters for genotype and interaction effects. Note: a overlap between the area associated with the effect of
rs2254298 genotype (in green) and the effect of rs53576 genotype (in red). b overlap between the area associated with the interaction effects of
diagnosis and rs2254298 (in green), rs53576 (in red), and rs2268491 (in blue)
Table 4 Association between brain activity in the right
supramarginal gyrus and autism traits
Correlation with AQ Autism group Control group
rs53576 Genotype × diagnosis r = .342, p = .041* r = − .179, p = .327
Genotype r = .221, p = .196 r = − .136, p = .459
rs2254298 Genotype × diagnosis r = .067, p = .699 r = − .151, p = .410
Genotype r = .246, p = .149 r = − .208, p = .254
rs2268491 Genotype × diagnosis r = .088, p = .603 r = − .150, p = .404
AQ autism spectrum quotient (adolescent version) [81]
*Nominal significance
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congruent and incongruent conditions for self and other
was used as the outcome measure. Another study re-
ported no behavioural differences in performance on the
EEB task between adults with and without an autism
diagnosis, nor did they find differences in resting state
rSMG connectivity between groups [89]. The findings of
the current study suggest that the OXTR can explain
some of the within-group variability in self-other differ-
entiation, which is not otherwise captured by comparing
individuals with and without autism.
Other studies that examined OXTR genotype
within typical populations usually implicate areas of
the social brain other than the rSMG, such as the
amygdala or the ACC [50, 67–69, 90]. One possible
explanation for the results lies in the specific con-
trast used in the current analysis. We compared par-
ticipants’ brain activity in response to similar images
but using different prompts—sex judgments versus
mental states judgments. It is possible that during
the sex judgments, an automatic, implicit processing
of mental states was performed. Therefore, the unex-
pected activation pattern in the current study could
be a result of this different type of comparison. Im-
portantly, an analysis of the full sample, from which
the current sample was drawn, revealed differential
activation within the inferior frontal gyrus, temporal
pole, and retrosubicular area [74]. It is the addition
of the genotype information (within a subsample)
which revealed a different effect. Therefore, a careful
interpretation of the current findings in light of the
aforementioned previous research is that differential
activity in the rSMG, together with genotype, is a
marker of self-other distinction, crucial for the abil-
ity to correctly interpret the other’s mental state (as
opposed to over-relying on one’s own mental state).
Recent research suggests that the rSMG is connected
to other brain areas involved in empathy (anterior
insula and anterior cingulate cortex) and is responsible for
self-other differentiation in relation to empathic process-
ing [91]. It has been recently proposed that the observed
deficit in empathy in autism could be due to a reduced
ability to differentiate between self and other in the social
domain [92]. This interpretation of the findings is in line
with research pointing to the role of oxytocin as modulat-
ing the salience of social stimuli [57, 93, 94], and perhaps
more accurately shifting one’s focus from self to other.
Several limitations beg a cautious interpretation of the
current findings. It is important to note that an adoles-
cent sample was used in this study. On the one hand,
this constitutes a limitation, as developmental and pu-
bertal stages have not been directly assessed. However,
we dealt with this by controlling for age and sex, as well
as creating a study-specific brain template based on the
age and sex composition of the participants. On the
other hand, the adolescent sample is a strength of this
study as few studies have focused on this age group. In
addition, while brain overgrowth in the early stages of
development has been repeatedly associated with autism
[95], many of these brain differences tend to disappear
as children grow older, and brain volume during adoles-
cence is comparable to that of typically developing chil-
dren [96].Although, one study reported on accelarated
cortical thinning during adolescence, as compared to
typical adolescents [99]. Later in life brain volume de-
creases faster in autism as compared to typical adults
[97, 98].Although another study reported on accelerated
cortical thinning during adolescence, as compared to
typical adolescents [99]. As such, the current study high-
lights effects that persist into later stages of develop-
ment, but findings should be interpreted with caution,
and future research would benefit from investigating
similar effects in other age groups, taking a developmen-
tal approach. Another limitation is that of sample size,
although our sample size was modest as compared to
Table 5 Predicting diagnostic status
rs2268491 rs2254298 rs53576
B Sig OR B Sig OR B Sig OR
Sex − 1.066 .073 .345 − 1.185 .053 .306 − 1.401 .020 .246
Age .161 .332 1.174 .179 .290 1.196 .201 .226 1.223
rSMG activation − 1.419 .018* .242 − 1.599 .014* .202 − 1.051 .068 .350
Genotype − .599 .412 .549 − .347 .645 .707 .704 .285 2.022
rSMG x genotype 2.318 .007* 10.152 2.516 .005* 12.377 − 1.814 .035* .163
Prediction accuracy
Autism 75.7% 75.0% 72.2%
Control 63.6% 65.6% 59.4%
Overall 70.0% 70.6% 66.2%
OR odds ratio, rSMG right supramarginal gyrus
*Values significant at the p < .05 level
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other imaging genetics studies. We emphasise that, due
to the exploratory nature of the current study, replica-
tion and extension studies are needed to substantiate the
current findings.
Conclusions
This is one of the first studies, to our knowledge, to in-
corporate OXTR genotype and brain function data in
order to better understand the biological underpinnings
of social cognition and cognitive empathy in autism. The
current study further supports the involvement of oxyto-
cin in the aetiology of autism and simultaneously sug-
gests a mechanism for this effect, through activation of
the rSMG, an important part of the social brain, in re-
sponse to a test of cognitive empathy. Future studies,
utilising larger samples, are needed to substantiate this
effect and can be further used to answer additional ques-
tions, for example, regarding the role of sex and circulat-
ing levels of oxytocin on these effects. Given the
preliminary findings that implicate oxytocin as a thera-
peutic target, a greater understanding of the mechanism
by which oxytocin is involved in autism from genetics to
brain function, and how it contributes to variability
within autism, can advance the development of precise
therapeutic (both medical and non-medical)
interventions.
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